Geneva Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,954
Closed -$216K 90
2020
Q4
$216K Sell
3,954
-504
-11% -$26.3K 0.11% 91
2020
Q3
$223K Buy
+4,458
New +$216K 0.14% 78

Other funds holding IHI

Geneva Partners's IHI Position: Q1 2021 in Review

Geneva Partners sold out of iShares US Medical Devices ETF (IHI) in Q1 2021, closing a stake of 3,954 shares — an estimated $216K sold.

Geneva Partners first reported a position in IHI in Q3 2020 and held it in 2 quarters. The position peaked at $223K in Q3 2020. 566 funds tracked by Wall St. Rank hold IHI as of Q1 2021.

  • Geneva Partners reported no remaining iShares US Medical Devices ETF position as of Q1 2021 after selling out during the quarter.
  • Geneva Partners sold 3,954 iShares US Medical Devices ETF shares in Q1 2021, an estimated $216K.
  • Geneva Partners first reported a position in iShares US Medical Devices ETF in Q3 2020 and held it in 2 quarters.
  • Geneva Partners's iShares US Medical Devices ETF position peaked at $223K in Q3 2020.
  • 566 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2021.

Based on Geneva Partners's 13F filing for Q1 2021, filed 5 May 2021.